Pituitary cotransplantation significantly improves the performance, insulin content, and vascularization of renal subcapsular islet grafts

Diabetes

Volumn 48, Issue 1, 1999, Pages 59-65

  Davalli, Alberto M ^a   Scaglia, Luisa ^a   Brevi, Marco ^a   Sanvito, Francesca ^a   Freschi, Massimo ^a   Cavallaro, Ugo ^a   Parlow, Albert F ^b   Pontiroli, Antonio E ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL GRAFT; GRAFT SURVIVAL; HYPOPHYSIS TRANSPLANTATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY CAPSULE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; FOLLOW-UP STUDIES; GROWTH HORMONE; IMMUNOHISTOCHEMISTRY; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY; MALE; MICE; MICE, INBRED STRAINS; MICE, NUDE; PITUITARY GLAND; PROLACTIN;

EID: 0032913313     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.1.59     Document Type: Article

References (47)

1. Sharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Falqui L, Marchetti PM, Gingerich RL, Jaffe AS, Cryer PE, Anderson CB, Flye MW: Insulin independence after islet transplantation into type 1 diabetic patient. Diabetes 39:515-518, 1990
2. Warnock GL, Kneteman NM, Ryan E, Seelis REA, Rabinovich A, Rajotte RV: Normoglycemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34:55-58, 1991
3. Socci C, Falqui L, Davalli AM, Ricordi C, Braghi S, Bertuzzi F, Maffi P, Secchi A, Gavazzi F, Freschi M, Magistretti P, Socci S, Vignali A, Di Carlo V, Pozza G: Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Acta Diabetol 28:151-157, 1991
4. Weir GC, Bonner-Weir S: Scientific and political impediments to successful islet transplantation. Diabetes 46:1247-1256, 1997
5. Hering BJ: Insulin independence following islet transplantation in man: a comparison of different recipient categories. Int Islet Transpl Registry 6:5-19, 1996
6. Alejandro R, Cutfleld RG, Shienvold FL, Polonsky KS, Noel J, Olson L, Dillberger J, Miller J, Mintz DH: Natural history of intrahepatic canine islet cell autografts. J Clin Invest 78:1339-1348, 1986
7. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC: Vulnerability of islets in the immediate posttransplantation period: dynamic changes in structure and function. Diabetes 45:1161-1167, 1996
8. Montana E, Bonner-Weir S, Weir GC: Transplanted beta cell response to increased metabolic demand: changes in beta cell replication and mass. J Clin Invest 93:1577-1582, 1994
9. Parsons JA, Brelje TC, Sorenson RL: Adaptation of islets to pregnancy: increase in b-cell division and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 130:1459-1466, 1992
10. Brelje TC, Sharp DW, Lacy PE, Orgren L, Talamandes F, Robertson M, Friesen HG, Sorenson RL: Effect of homologous placental lactogens, prolactins, and growth hormones on islet β-cell division and insulin secretion in rat, mouse and human islets: implication for placental lactogen of islet function during pregnancy. Endocrinology 132:879-887, 1993
11. Brelje TC, Parsons JA, Sorenson RL: Regulation of islet β-cell proliferation by prolactin in rat islets. Diabetes 43:263-273, 1994
12. Sorenson RL, Stout LE: Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. Endocrinology 136:4092-4098, 1995
13. Parsons JA, Bartke A, Sorenson RL: Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology 136:2013-2021, 1995
14. Nielsen JH, Linde S, Welinder BS, Billestrup N, Ole Madsen D: Growth hormone is a growth factor for the differentiated pancreatic β-cell. Mol Endocrinol 13:165-173, 1989
15. Dionne KE, Colton CK, Yannush ML: Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans. Diabetes 42:12-18, 1993
16. Bonner-Weir S, Orci L: New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31:883-889, 1982
17. Brunicardi FC, Stagner J, Bonner-Weir S, Wayland H, Kleinman R, Livingston E, Guth P, Merger M, McCuskey R, Intaglietta M, Charles A, Ashley S, Cheung A, Ipp E, Gilman S, Howard T, Passaro E Jr: Microcirculation of the islets of Langerhans: Long Beach Veterans Administration Regional Medical Education Center Symposium. Diabetes 45:385-392, 1996
18. Ray D, Melmed S: Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228, 1997
19. Ferrara N, Henzel WJ: Pituitary follicular cells secret a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858, 1989
20. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci U S A 86:7311-7310, 1989
21. Ferrara N, Schweiger L, Neufeld G, Mitchell R, Gospodarowicz D: Pituitary follicular cells produce basic fibroblast growth factor. Proc Natl Acad Sci U S A 84:5773-5777, 1987
22. Cristofori G, Naik P, Hanahan D: Vascular endothelial growth factor and its receptor flt-1 and flk-1, are expressed in normal pancreatic: islets and throughout islet cell tumorigenesis. Mol Endocrinol 9:1760-1770, 1995
23. Shweiki D, Itin A, Soffer D, Keshef E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992
24. Gorden DL, Mandriota SJ, Montesano R, Orci L, Pepper MS: Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. Transplantation 63:430-443, 1997
25. Vajkoczy P, Olofsson AM, Lehr H-A, Leiderer R, Hammersen F, Arfors KE, Menger MD: Histogenesis and ultrastructure of pancreatic islet graft microvasculature: evidence for graft revascularization by endothelial cells of host origin. Am J Pathol 146:1376-1405, 1995
26. Jacobson MD, Raff MC: Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814-816, 1995
27. Himizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y: Prevention of hypoxia-induced cell death by Blc-2 and Bcl-xl. Nature 374:811-813, 1995
28. Weir GC, Davalli AM, Hollister J, Bonner-Weir S: Islet isolation from rodent pancreas. In Pancreatic Islet Transplantation. Vol. 1. Lanza RP, Chick WL, Eds. New York, RG Landes, 1994, p. 53-59
29. Adler RA: The anterior pituitary-grafted rat: a valid model of chronic hyperprolactinemia. Endocr Rev 7:302-312, 1986
30. Auguado LI, Rodriguez A, Bilbao A, Rodriguez EM: Cytological changes in the pars distalis of the female rat hypophysis grafted under the kidney capsule. Cell Tissue Res 199:539-543, 1979
31. Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh P, Welsh J-E: Active cell death in hormone-dependent tissues. Cancer Metastasis Rev 11:197-220, 1992
32. Missale C, Boroni F, Sigala S, Buriani A, Fabris M, Leon A, Dal Toso R, Spano PF: Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc Natl Acad Sci U S A 93:4240-1245, 1996
33. Polak M, Scharfmann R, Seilheimer B, Eisenbarth G, Dressler D, Verma IM, Potter H: Nerve growth factor induces neuronal-like differentiation of an insulin-secreting pancreatic beta cell line. Proc Natl Acad Sci U S A 90:5781-5885, 1993
34. Kanaka-Gantenbein C, Dicou E, Czernichow P, Scharfmann R: Presence of nerve growth factor and its receptors in an in vitro model of islet cell development: implication in normal islet morphogenesis. Endocrinology 136:3154-3162, 1995
35. Sher E, Rosa P, Bassetti M, Zanini A: Immunolocalization of secretogranin II and insulin in a nerve growth factor-differentiated insulinoma cell line. Eur J Cell Biol 67:15-22, 1995
36. Edward RH, Rutter WJ, Hanahan D: Direct expression of NGF to pancreatic beta cells in transgenic mice leads to selective hyperinnervation of the islets. Cell 58:161-170, 1989
37. Landgraft R, Landgraft-Leurs MM, Weissmann A, Horl R, Von Werder K, Scriba PC: Prolactin: a diabetogenic hormone. Diabetologia 13:99-104, 1977
38. Martin JM, Hans KA, Garay G: Insulin secretion in rats with elevated levels of circulating growth hormone due to MtT-W15 Tumor. Diabetes 17:661-667, 1968
39. Akerblom HK, Martin JM, Garay GL, Moscatello M: Experimental hypersomatotropism. Metabolic effects in rats bearing the MtT-W15 tumor. Horm Metab Res 4:15-21, 1972
40. Garay GL, Akerblom HK, Martin JM: Experimental hypersomatotropism: serum growth hormone and insulin, and pituitary and pancreatic changes in MtT-W15 tumor-bearing rats before and after tumor removal. Horm Metab Res 3:82-89, 1971
41. Bates RW, Scow RO, Lacy PE: Induction of permanent diabetes in rats by pituitary hormones from a transplantable mammotropic tumor: concomitant changes in organ weight and the effect of adrenalectomy. Endocrinology 78:826-839, 1965
42. Adler RA, Sokol HW: Glucose tolerance in rats with elevated circulating prolactin levels. Horm Metab Res 14:307-309, 1982
43. Matsuda M, Mori T: Effect of estrogen on hyperprolactinemia-induced glucose intolerance in SHN mice. Proc Soc Eng Biol Med 212:243-247, 1996
44. Matsuda M, Mori T, Park MK, Sassa S, Sakamoto S, Kawashima S: Chronic effect of hyperprolactinemia on blood glucose and lipid levels in mice. Life Sci 58:1171-1177
45. Shirasawa N, Kihara H, Yamagucni S, Yoshimura F: Pituitary folliculo-stellate cells immunostained with S-100 protein antiserum in postnatal, castrated and thyroidectomized rat. Cell Tissue Res 231:235-248, 1983
46. Brier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521-532, 1992
47. Ohzato H, Porter J, Monaco AP, Montana E, Maki T: Minimum number of islets required to maintain euglycemia and their reduced immunogenicity after transplantation into diabetic mice. Transplantation 56:270-274, 1993